Gyon Technologies Capital Management, LP Mirum Pharmaceuticals, Inc. Transaction History

Gyon Technologies Capital Management, LP

  • $0
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$16.29 - $21.92 $194,649 - $261,922
-11,949 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$15.75 - $25.45 $188,196 - $304,102
11,949 New
11,949 $209,000
Q3 2020

Nov 16, 2020
SELL
$18.4 - $26.59 $347,300 - $501,886
-18,875 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$11.51 - $20.97 $217,251 - $395,808
18,875 New
18,875 $367,000

Others Institutions Holding MIRM

# of Institutions
225
Shares Held
55.4M
Call Options Held
27.4K
Put Options Held
105K
View Full List

About Mirum Pharmaceuticals, Inc.

MIRM Quotes by TradingView
  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.64B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email